By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


LEO Pharma 

Industriparken 55
DK-2750 Ballerup
Copenhagen      Denmark
Phone: 45-4492-3800 Fax: 45-4494-3040



Company News
Fidelta Achieves Milestone In Collaboration With LEO Pharma 3/3/2015 8:11:05 AM
LEO Pharma Announces New Drug Application Submission of the First Aerosol Foam for Plaque Psoriasis 1/6/2015 7:56:09 AM
LEO Pharma Appoints Barbara Osborne As President & CEO Of LEO U.S. Region 11/19/2014 10:41:41 AM
LEO Pharma And Japan Tobacco Enter Into License Agreement For Novel JAK inhibitor Drug Candidate 11/4/2014 9:59:51 AM
LEO Pharma Announced New Taclonex® (Calcipotriene And Betamethasone Dipropionate) Topical Suspension, 0.005%/0.064% Indication For Treatment Of Scalp Plaque Psoriasis In Pediatric Patients Ages 12-17 9/30/2014 10:00:58 AM
LEO Pharma & Klox Technologies Strike Global Dermatology Deal 7/15/2014 8:52:07 AM
Antares Pharma, Inc. (ATRS) Receives Second Milestone Payment From LEO Pharma In OTREXUP Collaboration 3/12/2014 7:11:07 AM
Antares Pharma, Inc. (ATRS) Announces LEO Pharma’s Launch Of OTREXUP (Methotrexate) Injection To Dermatologists For Adults With Psoriasis 3/10/2014 9:00:25 AM
Antares Pharma, Inc. (AIS) Enters Into An Exclusive U.S. Promotion And Marketing Agreement With LEO Pharma For OTREXUP™ In Dermatology 11/14/2013 9:26:16 AM
LEO Pharma Expands QualityCare™ Patient Support Program 10/28/2013 11:14:44 AM